Research and Development

Showing 15 posts of 9594 posts found.

ctca_-gerard-van-grinsven-90-2-1367000496mr

CTCA changes leadership

April 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTCA

The Cancer Treatment Centers of America (CTCA) network has made a change in its executive leadership with the appointment of  …
Merck image

Melanoma breakthrough for Merck

April 26, 2013 Research and Development, Sales and Marketing FDA, Merck, lambrolizumab, melanoma

Merck’s pipeline has been given a boost by an FDA decision to designate early-stage investigational drug lambrolizumab as a breakthrough …

Pharma R&D ‘untenable’

April 25, 2013 Research and Development, Sales and Marketing GlobalData, R&D

The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …

Boehringer’s online PMCPA breach

April 25, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA

Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …

Navigating Cancer hires VP from InVentiv Health

April 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health, navigating cancer

Cancer support service company Navigating Cancer has appointed Suzanne Greenwood to the firm as vice president, Bio-Pharmaceutical Services. Greenwood has …

£50m oncology fund pays out

April 24, 2013 Research and Development, Sales and Marketing Cancer, ICR, MPS1

The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …

Roche restructures life science business

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts

Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …
msi

The competitor room comes of age

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, competitor room

It was great to be back at SonoPharm, it was so still at this time of day and she went …

Specialist publisher acquires Pharmafile portfolio

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Samedan, Wiley, pharmafile

Samedan Ltd has extended its range of market-leading pharmaceutical magazines with the acquisition of the Pharmafile portfolio. The London-based firm …
Merck image

HCV agreement for Merck and BMS

April 23, 2013 Research and Development, Sales and Marketing BMS, HCV, Merck

Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …
astrazeneca image

AstraZeneca signs $200m nanomedicine deal

April 23, 2013 Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine

AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …
mike_narachi_orexigen

Orexigen’s chief executive elected to PhRMA Board

April 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen

Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …
abpi_reception

‘No consensus’ on transparency

April 22, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …
granger_nhs

New appointments to advise ministers on proposed NHS changes

April 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, granger, reforms

The Department of Health has announced that five new members will join the Independent Reconfiguration Panel (IRP) from May. The …
stephen-williams

Venaxis appoints former Pfizer executive to Board of directors

April 19, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, venaxis, williams

Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.  
The Gateway to Local Adoption Series

Latest content